DSIP: What the Name Describes and Where the Literature Stands
DSIP is a case where the name of a compound has outlasted the confidence of the finding that produced it. Using it well as a research material means understanding that history.
Origin of the name
DSIP is a nonapeptide, sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, isolated in the 1970s from cerebral venous blood of rabbits in an induced sleep state. The name records the experimental context in which it was found. It is a description of a historical isolation procedure, not an established pharmacological classification.
Why the literature is difficult
Three features make this body of work harder to interpret than most peptide literatures, and a researcher planning experiments should account for all three.
First, no receptor has been definitively identified. Without a defined molecular target there is no binding assay, no selectivity data and no structure-activity series of the kind available for receptor-targeted peptides.
Second, replication has been inconsistent. Several early reports were not reproduced, and the field contracted substantially as a result. Much of the available material dates from a period with different reporting standards than are now expected.
Third, the peptide is reported to be rapidly degraded in plasma, which complicates interpretation of any in vivo work and makes exposure difficult to establish.
The indexed literature is available at PubMed. It is a comparatively small corpus, and reading it chronologically is informative.
Implications for experimental design
For a compound without an identified receptor, the burden on controls is higher. Vehicle controls, scrambled-sequence controls and independent replication within a laboratory carry more weight than they would for a compound with a validated target. Claims resting on a single reported effect in a single model should be treated as provisional.
Handling
DSIP contains a tryptophan residue at the N-terminus. Tryptophan is among the more oxidation-prone and light-sensitive residues, so amber vials or foil-wrapped containers and minimal exposure to ambient light are sensible precautions. Oxidation products typically appear as additional early-eluting peaks on RP-HPLC. Storage guidance is covered in our storage and stability note. Product page: DSIP 5mg.
ExoLabz supplies compounds for laboratory research use only. Nothing on this page is medical advice or a suggestion of human or veterinary use. Certificates of analysis for each compound are published on this site.
